INTERPACE BIOSCIENCES, INC. Proceeds from Sale of Equity Method Investments
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Proceeds from Sale of Equity Method Investments of $383.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2025-03-31
- INTERPACE BIOSCIENCES, INC. proceeds from sale of equity method investments for the quarter ending 2023-12-31 was -$117.00K.
- INTERPACE BIOSCIENCES, INC. proceeds from sale of equity method investments for the quarter ending 2022-12-31 was -$903.00K.
- INTERPACE BIOSCIENCES, INC. proceeds from sale of equity method investments for fiscal 2023 was $383.00K, a 94.13% decline from fiscal 2022.
- INTERPACE BIOSCIENCES, INC. proceeds from sale of equity method investments for fiscal 2022 was $6.53M.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|
| 2023-12-31 | -$117.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-04-01 | $383.00K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $500.00K 10-K · filed 2025-03-31 | ||
| 2022-12-31 | -$903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $6.53M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $7.43M 10-Q · filed 2023-11-08 |